Ribomic Inc.

2026/09/29 18:54 Updated
Market Cap: $28.0M (¥4.4B)
Stock Price: $0.50 (¥78)
Exchange Rate: 1 USD = ¥157.23

Notice of Public Disclosure of JRCT Registration Information for Domestic Phase III Clinical Trial of Growth Hormone-Deficient Osteogenesis/Osteochondral Hypoplasia Treatment (umedaptanib pegol)

Importance:
Page Updated: September 21, 2026
IR Disclosure Date: July 8, 2026
Other

Ribomic Inc.

Company overview · Stock price · Financial data · All IR

View company page →